Substitute for Raised S.B. No. 925
Session Year 2017
 


AN ACT CONCERNING THE COST OF PRESCRIPTION DRUGS AND VALUE-BASED INSURANCE DESIGN.

To: (1) Require manufacturers of prescription drugs to disclose pricing information to the Insurance Commissioner; (2) require that certain insurance policies incorporate value-based insurance design; and (3) establish a task force to study methods of controlling the cost of prescription drugs.

Introduced by:
Insurance and Real Estate Committee

 New today  2-4 days old  5 days & older

*NOTE: Add to My Bills and Add Notes are cookie-based functions. If device cookies are cleaned, this information will be lost.

*NOTE: Add to My Bills and Add Notes are cookie-based functions. Browser must accept cookies from cga.ct.gov to function. If browser cookies are cleaned, bills will be lost.

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 3/30/2017(LCO)File Number 345
 3/30/2017House Calendar Number 252
 3/30/2017Tabled for the Calendar, House
 3/30/2017Favorable Report, House Committee on Insurance and Real Estate
 3/30/2017(LCO)Reported Out of Legislative Commissioners' Office
 3/24/2017(LCO)Referred to Office of Legislative Research and Office of Fiscal Analysis 03/29/17 5:00 PM
 3/16/2017(LCO)Filed with Legislative Commissioners' Office
 3/15/2017(INS)House Favorable Substitute
 3/15/2017(INS)Motion Failed SF
 3/3/2017Public Hearing 03/07
 2/24/2017Referred to Joint Committee on Insurance and Real Estate

Co-sponsors of SB-925

Sen. Martin M. Looney, 11th Dist.

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.